MarketPeel
Insider Trading Intelligence
Pricing
…
PR

Peter Rahmer

RLAY
SEE REMARKS · RELAY THERAPEUTICS, INC. · CIK 0001959229
FILING MIX · LIFETIME23%/77%
BUYS
12
SELLS
40
TOTAL VALUE
$3.10M
COMPANIES
1
ACTIVE SINCE
Jan 2023
HOLDINGS NOW
228,913
AVG SELL PX
$7.66
TRADE KIND
SHOWING 52 / 52
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
39 backtested trades · 8 horizons · 34 pending
Forward-return performance of every backtestable P/S trade by Peter Rahmer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d39+51.28%-1.34%-0.50%-0.83%-0.45%-0.61
14d39+66.67%-5.20%+0.87%-6.07%-8.63%-3.30
30d39+64.10%-5.74%+1.38%-7.50%-12.20%-2.80
60d39+61.54%-3.97%+2.04%-6.00%-14.41%-1.54
90d39(1 pending)+57.89%-3.91%+3.63%-7.54%-19.71%-1.23
180d39(3 pending)+77.78%-3.86%+9.97%-13.84%-26.19%-1.58
1y39(7 pending)+65.63%+12.79%+20.15%-7.36%-62.12%-0.41
2y39(23 pending)+56.25%+5.42%+44.23%-52.78%-83.97%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RLAY · 228,913 shares · as of Jun 30, 2026
0129,157258,314387,471516,628202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 12 buys / 40 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,056$6.95$21.2K228,913Jun 30, 2026Jul 2, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
50,000$19.09$954.5K225,857Jun 30, 2026Jul 2, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
753$14.79$11.1K275,857Apr 28, 2026Apr 30, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,354$8.45$11.4K276,610Jan 28, 2026Jan 29, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
11,684$7.62$89.0K277,964Jan 27, 2026Jan 29, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
475,000——475,000Jan 13, 2026Jan 15, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
994$2.99$3.0K338,463Dec 31, 2025Jan 29, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
21,394$7.50$160.5K337,469Oct 29, 2025Oct 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
19,135$7.29$139.5K358,863Oct 28, 2025Oct 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
15,724$3.68$57.9K377,998Jul 29, 2025Jul 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,359$3.74$5.1K393,722Jul 28, 2025Jul 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,000$2.94$14.7K395,081Jun 30, 2025Jul 1, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
10,739$3.00$32.2K390,081Apr 30, 2025Apr 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,364$3.17$4.3K400,820Apr 28, 2025Apr 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
247$2.84$701402,184Mar 27, 2025Mar 31, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
17,250$4.42$76.2K402,431Jan 30, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
26,541$4.55$120.8K419,681Jan 29, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
139,141——446,222Jan 28, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,673$4.63$7.7K307,081Jan 28, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
275,000——275,000Jan 10, 2025Jan 14, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
16,576$4.45$73.8K308,754Jan 6, 2025Jan 6, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
32,177$4.30$138.4K325,330Jan 3, 2025Jan 6, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
32,156$4.15$133.4K357,507Jan 2, 2025Jan 6, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
400$4.38$1.8K389,663Dec 27, 2024Dec 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,621$6.06$9.8K390,063Oct 28, 2024Oct 30, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
245$7.51$1.8K391,684Sep 27, 2024Oct 1, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,708$8.19$112.3K391,929Jul 31, 2024Jul 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
15,128$8.28$125.3K405,637Jul 30, 2024Jul 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,359$8.85$12.0K432,929Jul 29, 2024Jul 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,164$8.51$103.5K420,765Jul 29, 2024Jul 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,108$5.54$11.7K434,288Jun 30, 2024Jul 1, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
245$6.26$1.5K432,180Jun 27, 2024Jul 1, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,450$7.06$144.4K432,425Jun 5, 2024Jun 5, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
40,595$6.64$269.6K452,875Jun 4, 2024Jun 5, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
19,864$6.47$128.5K493,470Jun 3, 2024Jun 5, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,345$6.38$8.6K513,334Apr 29, 2024Apr 29, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
298$7.70$2.3K514,679Mar 27, 2024Mar 29, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,651$9.64$15.9K514,977Jan 29, 2024Jan 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——516,628Jan 16, 2024Jan 18, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
244$11.51$2.8K316,628Dec 27, 2023Dec 29, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,354$6.03$8.2K316,872Oct 30, 2023Nov 1, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
244$8.38$2.0K318,226Sep 27, 2023Sep 29, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,352$11.80$16.0K316,808Jul 28, 2023Jul 31, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,662$10.68$17.8K319,822Jun 30, 2023Sep 29, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
244$12.12$3.0K318,160Jun 27, 2023Jun 28, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
161,818——318,404May 30, 2023Jun 1, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
739$11.16$8.2K157,504Apr 28, 2023May 1, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
1,657$11.16$18.5K156,586Apr 28, 2023Jun 1, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
297$15.36$4.6K158,243Mar 27, 2023Mar 28, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
See remarks
740$21.56$16.0K158,540Jan 30, 2023Jan 31, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
97,630——159,280Jan 17, 2023Jan 19, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
97,630——97,630Jan 17, 2023Jan 19, 2023 ↗View →
Other insiders · RLAY
Loading peer insiders…
About this filer
CIK 0001959229
ROLE
See remarks
PRIMARY
RLAY
COMPANIES
1
ACTIVE SINCE
Jan 2023
MARKETPEEL · /INSIDER/0001959229DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback